
Request Appointment
530 East 74th StreetNew York, NY 10021
Overview of Dr. Schoenfeld
Dr. Adam Schoenfeld is an oncologist in New York, NY and is affiliated with Memorial Sloan Kettering Cancer Center. He received his medical degree from University of California San Francisco School of Medicine and has been in practice 12 years. He is one of 527 doctors at Memorial Sloan Kettering Cancer Center who specialize in Oncology. He has more than 90 publications and over 500 citings.
Education & Training
Westchester Medical CenterResidency, Gastroenterology, 2020 - 2026
University of California (San Francisco)Residency, Internal Medicine, 2014 - 2017
University of California San Francisco School of MedicineClass of 2014, AOA
Certifications & Licensure
CA State Medical License 2016 - Present
FL State Medical License 2021 - Present
NJ State Medical License 2020 - 2027
NY State Medical License 2017 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Kaiser Permanente Medical Student Scholarship Award Kaiser Permanente, 2013
- New England Journal of Medicine Scholar New England Journal of Medicine, 2012
- Phi Beta Kappa Society Member Dartmouth College, 2009
Publications & Presentations
PubMed
- 1 citationsTTF-1 Expression in Lung Adenocarcinoma: Clinicopathologic, Genomic, and Immunophenotypic Correlates and Outcomes to Immunotherapy-Based Treatments and KRASInhibitors.Alessandro Di Federico, Lingzhi Hong, Arielle Elkrief, Rohit Thummalapalli, Alissa J Cooper
Journal of Thoracic Oncology. 2026-07-01 - Bleeding in patients with lung adenocarcinoma receiving concurrent administration of anticoagulation and vascular endothelial growth factor or epidermal growth factor ...Thomas F Fusillo, Avi Leader, Simon Mantha, Helen Ajufo, Andriy Derkach
Journal of Thrombosis and Haemostasis. 2026-06-05 - Impact of KRAS Mutations and Co-Alterations on Outcomes in Stage III Nonsquamous NSCLC Treated With Chemoradiation and Immunotherapy.Nikhil P Mankuzhy, Valentina Santo, Jacob Y Shin, Tafadzwa L Chaunzwa, Daphna Y Gelblum
Journal of Thoracic Oncology. 2026-06-01
Journal Articles
- Effect of Osimertinib and Bevacizumab on Progression-Free Survival for Patients with Metastatic EGFR-Mutant Lung CancersHelena A Yu, Adam J Schoenfeld, Jamie E Chaft, Gregory J Riely, JAMA Oncology
- Synthesis, Structure, Dynamics, and Selective Methylation of Platinum and Palladium Diphosphametallacyclobutane ComplexesChapp TW, Schoenfeld A, Sanderson MD, Chang C, Glueck DS, Golen J, Moore C, Rheingold A, Organometallics, 2012
- Effects of Linker Length on the Rate and Selectivity of Platinum-Catalyzed Asymmetric Alkylation of the Bis(isitylphosphino)alkanes IsHP(CH2)nPHIs (is = 2,4,6-(i-pr)3C...Chapp TW, Schoenfeld A, Glueck DS, Organometallics, 2010
Press Mentions
Synthekine Presents Positive Initial Results from Phase 1a/1b Clinical Trial of STK-012 plus Pembrolizumab and Chemotherapy in First-Line, PD-L1 Negative Nonsquamous Non-Small Cell Lung CancerNovember 7th, 2025
Clinical Late-Breaking Abstracts Announced for the Society for Immunotherapy of Cancer's 40th Anniversary Annual MeetingOctober 30th, 2025
Study Finds Growing Reason to Be Wary of Some Reflux DrugsJanuary 29th, 2016
Grant Support
- DLL3-targeted IL18-secreting CAR T cells in Small Cell Lung CancerSLOAN-KETTERING INST CAN RESEARCH2025–2030
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:


